Trial intelligence / Profile preview

Desflurane vs. Propofol for Cardiac Anesthesia in CABG

NCT07116733Phase 3Recruiting

Sponsor
Xijing Hospital
Start
Oct 2025
Primary completion
Dec 2028
Modality
Allosteric Modulators
Countries
1
01

Overview

A Phase 3 trial of desflurane in coronary artery disease (CAD), sponsored by Xijing Hospital. Started Oct 2025; status: recruiting.

02

Drugs

desflurane
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT07116733.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07116733.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call